Epidermicin (Amprologix)
N/A
Report date: 2025/10/23 16:37:50
NMEFirst In Class
Base Information
Drug NameEpidermicin (Amprologix)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Plymouth
China Registration ClassN/A
Develop Information
Active CompaniesAmprologixUniversity Of Plymouth
Inactive CompaniesThe University Of Manchester
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A